Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Val Gebski

Showing results (61-70 of 248) with videos related to

Pageof 25
Sort By:
Journal of Medical Imaging and Radiation Oncology|February 7, 2017
Whole breast hypofractionation: Trials, guidelines and clinical practiceRuth Conroy, Val Gebski, Drew Latty, et al.
Obstetrics and Gynecology|March 24, 2009
Outcome and patterns of recurrence for International Federation of Gynecology and Obstetrics (FIGO) stages I and II squamous cell vulvar cancerCharuwan Tantipalakorn, Greg Robertson, Donald E Marsden, et al.
Evidence-Based Medicine|May 27, 2017
Criticisms of the VAPOUR trial in a recent commentary are unsubstantiated and incorrectWilliam Clark, Paul Bird, Terry Diamond, et al.
American Journal of Obstetrics and Gynecology|January 7, 2018
Pelvic floor functional outcomes after total abdominal vs total laparoscopic hysterectomy for endometrial cancerPeta Higgs, Monika Janda, Rebecca Asher, et al.
Cancer Medicine|June 19, 2021
Weight and weight control behaviors during long-term endometrial cancer survivorship: Results of the Laparoscopic Approach to Cancer of the Endometrium long-term follow-up studyMonika Janda, Peta Forder, Val Gebski, et al.
Bioinformatics Advances|November 6, 2023
Improving efficiency of fitting Cox proportional hazards models for time-to-event outcomes in genome-wide association studies (GWAS)Val Gebski, S Sandun M Silva, Karen Byth, et al.
Journal of Medical Radiation Sciences|September 20, 2023
Australian radiation therapist's research capacity and culture: investigating the extent of assistance required to build research capacityRachael Beldham-Collins, Georgia K B Halkett, Kellie Knight, et al.
The Lancet. Oncology|March 3, 2007
Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysisVal Gebski, Bryan Burmeister, B Mark Smithers, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 15, 2007
Differential risk assessments from five hypoxia specific assays: The basis for biologically adapted individualized radiotherapy in advanced head and neck cancer patientsMarianne Nordsmark, Jesper Grau Eriksen, Val Gebski, et al.
Melanoma Research|February 6, 2003
Patterns of metastases in familial and non-familial melanomaJoanne Hornbuckle, Gordana Culjak, Elizabeth Jarvis, et al.
Pageof 25

Showing results (61-70 of 248) with videos related to

Sort By:
Pageof 25
Journal of Medical Imaging and Radiation Oncology|February 7, 2017
Whole breast hypofractionation: Trials, guidelines and clinical practiceRuth Conroy, Val Gebski, Drew Latty, et al.
Obstetrics and Gynecology|March 24, 2009
Outcome and patterns of recurrence for International Federation of Gynecology and Obstetrics (FIGO) stages I and II squamous cell vulvar cancerCharuwan Tantipalakorn, Greg Robertson, Donald E Marsden, et al.
Evidence-Based Medicine|May 27, 2017
Criticisms of the VAPOUR trial in a recent commentary are unsubstantiated and incorrectWilliam Clark, Paul Bird, Terry Diamond, et al.
American Journal of Obstetrics and Gynecology|January 7, 2018
Pelvic floor functional outcomes after total abdominal vs total laparoscopic hysterectomy for endometrial cancerPeta Higgs, Monika Janda, Rebecca Asher, et al.
Cancer Medicine|June 19, 2021
Weight and weight control behaviors during long-term endometrial cancer survivorship: Results of the Laparoscopic Approach to Cancer of the Endometrium long-term follow-up studyMonika Janda, Peta Forder, Val Gebski, et al.
Bioinformatics Advances|November 6, 2023
Improving efficiency of fitting Cox proportional hazards models for time-to-event outcomes in genome-wide association studies (GWAS)Val Gebski, S Sandun M Silva, Karen Byth, et al.
Journal of Medical Radiation Sciences|September 20, 2023
Australian radiation therapist's research capacity and culture: investigating the extent of assistance required to build research capacityRachael Beldham-Collins, Georgia K B Halkett, Kellie Knight, et al.
The Lancet. Oncology|March 3, 2007
Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysisVal Gebski, Bryan Burmeister, B Mark Smithers, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 15, 2007
Differential risk assessments from five hypoxia specific assays: The basis for biologically adapted individualized radiotherapy in advanced head and neck cancer patientsMarianne Nordsmark, Jesper Grau Eriksen, Val Gebski, et al.
Melanoma Research|February 6, 2003
Patterns of metastases in familial and non-familial melanomaJoanne Hornbuckle, Gordana Culjak, Elizabeth Jarvis, et al.
Pageof 25